Fig. 1From: The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patientsMPS II electrophoresis profile on a cellulose acetate plate of urinary GAGs. 1, 2 and 5: MPS II patients; 3: MPS III patients; 4: Control case; CS: chondroïtin sulphate; DS: dermatansulfate; HS: heparan sulfate, KS: Keratan sulfateBack to article page